|
?:abstract
|
-
Today, COVID-19 pneumonia causes global concern The World Health Organization (WHO) has reported many mortalities from this disease all around the world Therefore, recognizing new cases of COVID-19 is crucial during this pandemic Many studies have shown that COVID-19 has a broad spectrum of signs and symptoms, including GI and cutaneous manifestations Previous studies have reported liver enzyme changes as well as diarrhea as a common GI manifestation of COVID-19 However, there are few reports about COVID-19 synchronous cutaneous and liver involvement Additionally, there are few reports about intrahepatic cholestasis in COVID-19 patients In this article, a confirmed case of COVID-19 with vasculopathy-related cutaneous manifestation and liver cholestasis is reported A 67-year-old Iranian woman was admitted to Taleghani Hospital with epigastric pain, vomiting, anosmia, rising liver enzyme levels, fever, itching, and skin rashes Skin and liver biopsies were performed during the patient’s admission;the results suggested vasculopathy-related cutaneous lesion and liver cholestasis Plasmapheresis was initiated and all manifestations disappeared after treatment All atypical presentations, including cutaneous lesions and liver manifestations, should be considered as COVID-19 and evaluated © 2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}